Reactive oxygen species- and DNA damage response-dependent NK cell activating ligand upregulation occurs at transcriptional levels and requires the transcriptional factor E2F1

Journal of Immunology

Volumn 193, Issue 2, 2014, Pages 950-960

  Soriani, Alessandra ^a   Iannitto, Maria Luisa ^a   Ricci, Biancamaria ^a   Fionda, Cinzia ^a   Malgarini, Giulia ^a   Morrone, Stefania ^b   Peruzzi, Giovanna ^c   Ricciardi, Maria Rosaria ^b   Petrucci, Maria Teresa ^b   Cippitelli, Marco ^a   Santoni, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DNA; GAMMA INTERFERON; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR E2F1;

ARTICLE; BONE MARROW; CELL AGING; CELL ISOLATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; MULTIPLE MYELOMA; MYELOMA CELL; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA DAMAGE; DOXORUBICIN; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE ACTIVATION; MALE; MELPHALAN; MULTIPLE MYELOMA; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; REACTIVE OXYGEN SPECIES; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84904265813     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400271     Document Type: Article

References (63)

1. Kroemer, G., L. Galluzzi, O. Kepp, and L. Zitvogel. 2013. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31: 51-72.
2. Gasser, S., S. Orsulic, E. J. Brown, and D. H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190. (Pubitemid 41232299)
3. Soriani, A., A. Zingoni, C. Cerboni, M. L. Iannitto, M. R. Ricciardi, V. Di Gialleonardo, M. Cippitelli, C. Fionda, M. T. Petrucci, A. Guarini, et al. 2009. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511.
4. Collado, M., and M. Serrano. 2010. Senescence in tumours: evidence from mice and humans. Nat. Rev. Cancer 10: 51-57.
5. Acosta, J. C., and J. Gil. 2012. Senescence: a new weapon for cancer therapy. Trends Cell Biol. 22: 211-219.
6. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49. (Pubitemid 33741974)
7. Ljunggren, H. G., and K. J. Malmberg. 2007. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7: 329-339.
8. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274. (Pubitemid 40563170)
9. Raulet, D. H., and N. Guerra. 2009. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat. Rev. Immunol. 9: 568-580.
10. Shibuya, A., D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, T. McClanahan, T. Kitamura, J. Nicholl, G. R. Sutherland, L. L. Lanier, and J. H. Phillips. 1996. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4: 573-581. (Pubitemid 26233311)
11. Bottino, C., R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, et al. 2003. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198: 557-567. (Pubitemid 37040390)
12. Raulet, D. H., S. Gasser, B. G. Gowen, W. Deng, and H. Jung. 2013. Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 31: 413-441.
13. Eagle, R. A., and J. Trowsdale. 2007. Promiscuity and the single receptor: NKG2D. Nat. Rev. Immunol. 7: 737-744. (Pubitemid 47327391)
14. Fuchs, A., and M. Colonna. 2006. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin. Cancer Biol. 16: 359-366. (Pubitemid 44311500)
15. Osterborg, A., B. Nilsson, M. Björkholm, G. Holm, and H. Mellstedt. 1990. Natural killer cell activity in monoclonal gammopathies: relation to disease activity. Eur. J. Haematol. 45: 153-157. (Pubitemid 20358753)
16. Carbone, E., P. Neri, M. Mesuraca, M. T. Fulciniti, T. Otsuki, D. Pende, V. Groh, T. Spies, G. Pollio, D. Cosman, et al. 2005. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 105: 251-258. (Pubitemid 40053090)
17. El-Sherbiny, Y. M., J. L. Meade, T. D. Holmes, D. McGonagle, S. L. Mackie, A. W. Morgan, G. Cook, S. Feyler, S. J. Richards, F. E. Davies, et al. 2007. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res. 67: 8444-8449. (Pubitemid 47437416)
18. Jinushi, M., M. Vanneman, N. C. Munshi, Y. T. Tai, R. H. Prabhala, J. Ritz, D. Neuberg, K. C. Anderson, D. R. Carrasco, and G. Dranoff. 2008. MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc. Natl. Acad. Sci. USA 105: 1285-1290. (Pubitemid 351397045)
19. Carnevale, J., O. Palander, L. A. Seifried, and F. A. Dick. 2012. DNA damage signals through differentially modified E2F1 molecules to induce apoptosis. Mol. Cell. Biol. 32: 900-912.
20. Fionda, C., G. Malgarini, A. Soriani, A. Zingoni, F. Cecere, M. L. Iannitto, M. R. Ricciardi, V. Federico, M. T. Petrucci, A. Santoni, and M. Cippitelli. 2013. Inhibition of glycogen synthase kinase-3 increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of STAT3. J. Immunol. 190: 6662-6672.
21. Fionda, C., A. Soriani, G. Malgarini, M. L. Iannitto, A. Santoni, and M. Cippitelli. 2009. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. J. Immunol. 183: 4385-4394.
22. Kurz, D. J., S. Decary, Y. Hong, and J. D. Erusalimsky. 2000. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J. Cell Sci. 113: 3613-3622.
23. Bryceson, Y. T., M. E. March, D. F. Barber, H. G. Ljunggren, and E. O. Long. 2005. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 202: 1001-1012. (Pubitemid 41396899)
24. Micucci, F., A. Zingoni, M. Piccoli, L. Frati, A. Santoni, and R. Galandrini. 2006. High-efficient lentiviral vector-mediated gene transfer into primary human NK cells. Exp. Hematol. 34: 1344-1352. (Pubitemid 44374838)
25. Borchers, M. T., N. L. Harris, S. C. Wesselkamper, M. Vitucci, and D. Cosman. 2006. NKG2D ligands are expressed on stressed human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L222-L231. (Pubitemid 44148106)
26. Yamamoto, K., Y. Fujiyama, A. Andoh, T. Bamba, and H. Okabe. 2001. Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2). Biochim. Biophys. Acta 1526: 10-12. (Pubitemid 32245765)
27. Jung, K., and R. Reszka. 2001. Mitochondria as subcellular targets for clinically useful anthracyclines. Adv. Drug Deliv. Rev. 49: 87-105. (Pubitemid 32493802)
28. Donepudi, M., P. Raychaudhuri, J. A. Bluestone, and M. B. Mokyr. 2001. Mechanism of melphalan-induced B7-1 gene expression in P815 tumor cells. J. Immunol. 166: 6491-6499. (Pubitemid 32467186)
29. Lu, T., and T. Finkel. 2008. Free radicals and senescence. Exp. Cell Res. 314: 1918-1922.
30. Solecki, D., S. Schwarz, E. Wimmer, M. Lipp, and G. Bernhardt. 1997. The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity. J. Biol. Chem. 272: 5579-5586. (Pubitemid 27102382)
31. Biswas, A. K., and D. G. Johnson. 2012. Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer Res. 72: 13-17.
32. Real, S., L. Espada, C. Espinet, A. F. Santidrián, and A. Tauler. 2010. Study of the in vivo phosphorylation of E2F1 on Ser403. Biochim. Biophys. Acta 1803: 912-918.
33. Balaban, R. S., S. Nemoto, and T. Finkel. 2005. Mitochondria, oxidants, and aging. Cell 120: 483-495. (Pubitemid 40269763)
34. Gasser, S., and D. H. Raulet. 2006. The DNA damage response arouses the immune system. Cancer Res. 66: 3959-3962.
35. Chan, C. J., M. J. Smyth, and L. Martinet. 2014. Molecular mechanisms of natural killer cell activation in response to cellular stress. Cell Death Differ. 21: 5-14.
36. Valés-Gómez, M., S. E. Chisholm, R. L. Cassady-Cain, P. Roda-Navarro, and H. T. Reyburn. 2008. Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors. Cancer Res. 68: 1546-1554. (Pubitemid 351346864)
37. Textor, S., N. Fiegler, A. Arnold, A. Porgador, T. G. Hofmann, and A. Cerwenka. 2011. Human NK cells are alerted to induction of p53 in cancer cells by up-regulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Res. 71: 5998-6009.
38. Li, H., T. Lakshmikanth, C. Garofalo, M. Enge, C. Spinnler, A. Anichini, L. Szekely, K. Kärre, E. Carbone, and G. Selivanova. 2011. Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. Cell Cycle 10: 3346-3358.
39. Heinemann, A., F. Zhao, S. Pechlivanis, J. Eberle, A. Steinle, S. Diederichs, D. Schadendorf, and A. Paschen. 2012. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res. 72: 460-471.
40. Mukhopadhyay, P., M. Rajesh, S. Bátkai, Y. Kashiwaya, G. Haskó, L. Liaudet, C. Szabó, and P. Pacher. 2009. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am. J. Physiol. Heart Circ. Physiol. 296: H1466-H1483.
41. Ardolino, M., A. Zingoni, C. Cerboni, F. Cecere, A. Soriani, M. L. Iannitto, and A. Santoni. 2011. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Blood 117: 4778-4786.
42. Peraldi, M. N., J. Berrou, N. Dulphy, A. Seidowsky, P. Haas, N. Boissel, F. Metivier, C. Randoux, N. Kossari, A. Guérin, et al. 2009. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J. Immunol. 182: 1696-1705.
43. Venkataraman, G. M., D. Suciu, V. Groh, J. M. Boss, and T. Spies. 2007. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J. Immunol. 178: 961-969. (Pubitemid 46095169)
44. Molinero, L. L., M. B. Fuertes, M. V. Girart, L. Fainboim, G. A. Rabinovich, M. A. Costas, and N. W. Zwirner. 2004. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J. Immunol. 173: 5583-5590. (Pubitemid 39392145)
45. Nausch, N., L. Florin, B. Hartenstein, P. Angel, M. Schorpp-Kistner, and A. Cerwenka. 2006. Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon. J. Immunol. 176: 7-11. (Pubitemid 43023242)
46. Cerboni, C., A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni. 2007. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood 110: 606-615. (Pubitemid 47105399)
47. Rodríguez-Rodero, S., S. González, L. Rodrigo, J. L. Fernández-Morera, J. Martínez-Borra, A. López- Vázquez, and C. López-Larrea. 2007. Transcriptional regulation of MICA and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur. J. Immunol. 37: 1938-1953. (Pubitemid 47065130)
48. Andresen, L., H. Jensen, M. T. Pedersen, K. A. Hansen, and S. Skov. 2007. Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells. J. Immunol. 179: 8235-8242.
49. Zhang, C., Y. Wang, Z. Zhou, J. Zhang, and Z. Tian. 2009. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis. Cancer Immunol. Immunother. 58: 1275-1285.
50. Carcagno, A. L., M. F. Ogara, S. V. Sonzogni, M. C. Marazita, P. F. Sirkin, J. M. Ceruti, and E. T. Cánepa. 2009. E2F1 transcription is induced by genotoxic stress through ATM/ATR activation. IUBMB Life 61: 537-543.
51. Lin, W. C., F. T. Lin, and J. R. Nevins. 2001. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15: 1833-1844.
52. Tanaka, H., I. Matsumura, S. Ezoe, Y. Satoh, T. Sakamaki, C. Albanese, T. Machii, R. G. Pestell, and Y. Kanakura. 2002. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol. Cell 9: 1017-1029. (Pubitemid 34626671)
53. Zhang, L., O. R. Sheppard, A. M. Shah, and A. C. Brewer. 2008. Positive regulation of the NADPH oxidase NOX4 promoter in vascular smooth muscle cells by E2F. Free Radic. Biol. Med. 45: 679-685.
54. Espada, L., N. Meo-Evoli, P. Sancho, S. Real, I. Fabregat, S. Ambrosio, and A. Tauler. 2012. ROS production is essential for the apoptotic function of E2F1 in pheochromocytoma and neuroblastoma cell lines. PLoS ONE 7: e51544.
55. Raimundo, N., L. Song, T. E. Shutt, S. E. McKay, J. Cotney, M. X. Guan, T. C. Gilliland, D. Hohuan, J. Santos-Sacchi, and G. S. Shadel. 2012. Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness. Cell 148: 716-726.
56. Jung, H., B. Hsiung, K. Pestal, E. Procyk, and D. H. Raulet. 2012. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. J. Exp. Med. 209: 2409-2422.
57. Schmitt, C. A. 2007. Cellular senescence and cancer treatment. Biochim. Biophys. Acta 1775: 5-20. (Pubitemid 44881196)
58. Krizhanovsky, V., M. Yon, R. A. Dickins, S. Hearn, J. Simon, C. Miething, H. Yee, L. Zender, and S. W. Lowe. 2008. Senescence of activated stellate cells limits liver fibrosis. Cell 134: 657-667.
59. Kang, T. W., T. Yevsa, N. Woller, L. Hoenicke, T. Wuestefeld, D. Dauch, A. Hohmeyer, M. Gereke, R. Rudalska, A. Potapova, et al. 2011. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479: 547-551.
60. Stagg, J., R. W. Johnstone, and M. J. Smyth. 2007. From cancer immunosurveillance to cancer immunotherapy. Immunol. Rev. 220: 82-101. (Pubitemid 350045568)
61. de Back, D. Z., E. B. Kostova, M. van Kraaij, T. K. van den Berg, and R. van Bruggen. 2014. Of macrophages and red blood cells; a complex love story. Front. Physiol. 5: 9.
62. Savill, J. S., A. H. Wyllie, J. E. Henson, M. J. Walport, P. M. Henson, and C. Haslett. 1989. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83: 865-875. (Pubitemid 19080618)
63. Rodier, F., and J. Campisi. 2011. Four faces of cellular senescence. J. Cell Biol. 192: 547-556.